Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Ganga Pharmaceuticals IPO and OFS Technologies IPO.
Ganga Pharmaceuticals IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while OFS Technologies IPO is a SME Fixed Price Issue proposed to list at BSE SME.
| Ganga Pharmaceuticals IPO | OFS Technologies IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Fixed Price Issue |
| Listing At | BSE SME | BSE SME |
| Lead Managers | First Overseas Capital Limited | V B Desai Financial Services Limited |
| Registrar | Kfin Technologies Limited | Bigshare Services Pvt Ltd |
| Market Maker | ||
| DRHP | DRHP  |
|
| RHP | RHP |
|
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Ganga Pharmaceuticals IPO is up to ₹1.54 Cr whereas the issue size of the OFS Technologies IPO is up to ₹4.25 Cr. The final issue price of Ganga Pharmaceuticals IPO is ₹15.00 per share and of OFS Technologies IPO is ₹25.00 per share.
| Ganga Pharmaceuticals IPO | OFS Technologies IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹15.00 per share | ₹25.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 8000 shares | 6000 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 10,24,000 shares | 17,00,000 shares |
| Issue Size Total (Amount) | up to ₹1.54 Cr | up to ₹4.25 Cr |
Ganga Pharmaceuticals IPO opens on Jan 29, 2016, while OFS Technologies IPO opens on Dec 28, 2015. The closing date of Ganga Pharmaceuticals IPO and OFS Technologies IPO is Feb 09, 2016, and Dec 31, 2015, respectively.
| Ganga Pharmaceuticals IPO | OFS Technologies IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jan 29, 2016 | Dec 28, 2015 |
| Issue Close | Feb 09, 2016 | Dec 31, 2015 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Ganga Pharmaceuticals IPO P/E ratio is , as compared to OFS Technologies IPO P/E ratio of .
| Ganga Pharmaceuticals IPO | OFS Technologies IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | ||
| Promoter Shareholding (Post-Issue) | ||
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW |
In the Ganga Pharmaceuticals IPO retail investors (RII) are offered while in OFS Technologies IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Ganga Pharmaceuticals IPO and in OFS Technologies IPO.
| Ganga Pharmaceuticals IPO | OFS Technologies IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
Ganga Pharmaceuticals IPO subscribed in total, whereas OFS Technologies IPO subscribed .
| Ganga Pharmaceuticals IPO | OFS Technologies IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
